Future Medicinal Chemistry
 | |
Abbreviated title (ISO 4) | Future Med. Chem. |
|---|---|
| Discipline | Medical chemistry |
| Language | English |
| Publication details | |
| Publisher |
Future Science |
Publication history | 2009–present |
| Frequency | 18/year |
| 3.744 | |
| Indexing | |
| ISSN |
1756-8919 (print) 1756-8927 (web) |
| CODEN | FMCUA7 |
| OCLC no. | 762952421 |
| Links | |
Future Medicinal Chemistry is a peer-reviewed medical journal covering all aspects of medicinal chemistry, including drug discovery, pharmacology, in silico drug design, structural characterization techniques, ADME-Tox investigations, and science policy, economic and intellectual property issues. It was established in 2009 and is published by Future Science. The editors-in-chief are Iwao Ojima (The State University of New York at Stony Brook) and Jonathan Baell (Monash University).
Abstracting and indexing
The journal is abstracted and indexed by BIOSIS Previews, Chemical Abstracts, Chemistry Citation Index, Embase/Excerpta Medica, Index Medicus/MEDLINE/PubMed, Science Citation Index Expanded, and Scopus. According to the Journal Citation Reports, the journal has a 2014 impact factor of 3.744, ranking it 8th out of 59 journals in the category "Chemistry, Medicinal".[1]
References
- ↑ "Journals Ranked by Impact: Chemistry, Medicinal". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015.